PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $798,915 | +145.5% | 33,150 | +7.7% | 0.01% | +100.0% |
| Q4 2022 | $325,387 | +134.9% | 30,784 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $138,528 | +288.8% | 30,784 | +245.6% | 0.00% | – |
| Q2 2022 | $35,632 | -85.0% | 8,908 | -72.5% | 0.00% | -100.0% |
| Q1 2022 | $237,285 | +469.6% | 32,416 | +337.3% | 0.00% | – |
| Q4 2021 | $41,661 | -68.5% | 7,413 | -64.2% | 0.00% | -100.0% |
| Q3 2021 | $132,384 | +93.9% | 20,685 | +155.4% | 0.00% | 0.0% |
| Q2 2021 | $68,275 | -69.9% | 8,099 | -62.5% | 0.00% | -50.0% |
| Q1 2021 | $226,650 | -31.8% | 21,596 | +10.0% | 0.00% | -33.3% |
| Q4 2020 | $332,481 | +32.0% | 19,627 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $251,814 | -9.1% | 19,627 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $276,937 | – | 19,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |